Cellipont Bioservices
Cell Therapy CDMO
- Headquarters
- Texas
- Employees
- 51–200
- Business Model
- B2B
- Website
- cellipont.com
- Last Round
- Venture RoundNov 2024
- Rounds
- 1
About
Contract development and manufacturing organization (CDMO) specializing in cell therapy development, analytics, and cGMP manufacturing.
Summary
Cellipont Bioservices is a Biotech company based in United States. Its most recent funding was a Venture Round round in Nov 2024. Investors include HealthQuest Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2024
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...